Teva Pharma (TEVA) Reports In-Line Q3 EPS, Offer FY Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Teva Pharma (TEVA) Reports In-Line Q3 EPS, Offer FY Guidance

Teva Reports Third Quarter 2020 Financial Results

November 5, 2020 7:00 AM EST

Revenues of $4.0 billion GAAP diluted loss per share of $3.97 Non-GAAP diluted EPS of $0.58 Free cash flow of $506 million Full year 2020 business outlook revised: Net revenues of $16.5-16.8 billion EBITDA of $4.7 - $4.9 billion EPS of $2.40 - $2.55 Free cash flow of $1.8 - $2.2 billion

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended September 30, 2020.

This press release features multimedia. View the... More